Alira Health Contributes to 2022 Bioregion Report on the Future of Catalan Life Sciences

News
Published on:
February 13, 2023

We are pleased to announce that we are a key contributor to the just released 2022 Bioregion Report, the benchmark study that analyzes the life sciences and healthcare sector in Catalonia, conducted by Biocat, BioRegion of Catalonia together with CataloniaBio & HealthTech and ACCIÓ. Our Market Access team aimed to analyze the main molecules that have entered the market based on innovation, and to identify those medical technology products that have accessed the market and how they have done so.

We were thrilled to contribute to the 2022 BioRegion Report, a one-of-a-kind in-depth analysis of the life sciences and biotechnology sector in Catalonia.
Chus Castillo Vice President Global Market Access Iberia, Alira Health

Some key findings from the report include –

  • Investment in startups and scaleups has exceeded all expectations in 2022, achieving 445 million euros in funding, boosted by the first mega round in the history of the BioRegion, captured by dental health medtech Impress, with 122 million euros.
  • Venture capital has once again been the primary source of financing, 95% of which involved international collaboration, followed by competitive grants (which have doubled compared to previous years), from the stock market, venture debt and crowdequity.
  • Financing from risk capital (venture capital) has once again been the main driver of this growth, accumulating 343 million euros, 77% of the total capital raised.
  • Foreign investment has also continued to hit record numbers. 95% of the total capital raised has included international investment companies. The number of international investment funds that have historically participated in operations has reached 117, a number that has doubled in the last three years.

This report was promoted at the presentation of the 2022 BioRegion Report on the 13th of February. The event was attended by institutional representatives of the Government of Catalonia and included a presentation of key indicators from the BioRegion Report and several expert round tables on innovation, investment and healthcare.

“We were thrilled to contribute to the 2022 BioRegion Report, a one-of-a-kind in-depth analysis of the life sciences and biotechnology sector in Catalonia. This report is a must-read for any stakeholder that is looking for a comprehensive overview of the activities of local companies, research facilities, and universities operating in the region. It provides a detailed view of the healthcare ecosystem in Catalonia as one of the leading regions in Europe in this sector,” said Chus Castillo, Vice President Global Market Access Iberia, Alira Health. “We hope that our contribution will enable healthcare companies to easily enter the Catalonian market and achieve maximum commercial success.”

Related news

News September 8, 2023
Alira Health Partners With Col·legi de Metges de Barcelona
We are pleased to partner with Col·legi de Metges de Barcelona (CoMB), an institution that represents and serves the almost 39,000 physicians in Barcelona.
Market Access Spain Startups
Events August 16, 2023
BioSpain
We are excited to attend, speak at, and sponsor BioSpain, one of the leading conferences in the European biotechnology field.
Biotech Spain
Events August 10, 2023
12th EPP Life Sciences Pricing Forum
We are excited to speak at the 12th EPP Life Sciences Pricing Forum for pricing directors and executives in Life Sciences.
EU Market Access
Events July 31, 2023
LSI Europe Emerging MedTech Summit
We will attend LSI Europe Emerging MedTech Summit in Barcelona to discuss the latest advancements, challenges, and trends in the industry.
MedTech Spain
Events July 31, 2023
World Vaccine Congress
We are pleased to announce that we will attend The World Vaccine Congress Europe, the largest and most established European meeting on vaccine R&D.
Drug Development Spain Vaccines
Events July 31, 2023
ESMO Congress
We are excited to join the ESMO Congress in Madrid. to disseminate the latest cutting-edge data for oncologists and other stakeholders.
Drug Development Market Access Oncology Spain
Publications July 25, 2023
Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets
Our Market Access experts have identified risks and opportunities associated with improving access to medicines in emerging countries.
Market Access Pharma
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.